UBS Group AG - THE ONCOLOGY INSTITUTE INC ownership

THE ONCOLOGY INSTITUTE INC's ticker is and the CUSIP is 68236X100. A total of 37 filers reported holding THE ONCOLOGY INSTITUTE INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS Group AG ownership history of THE ONCOLOGY INSTITUTE INC
ValueSharesWeighting
Q2 2023$1,328
-83.0%
2,414
-79.1%
0.00%
Q1 2023$7,823
-23.0%
11,538
+87.3%
0.00%
Q4 2022$10,165
+45.2%
6,161
+289.0%
0.00%
Q3 2022$7,000
+133.3%
1,584
+208.8%
0.00%
Q2 2022$3,000
-83.3%
513
-72.4%
0.00%
Q4 2021$18,0001,8590.00%
Other shareholders
THE ONCOLOGY INSTITUTE INC shareholders Q2 2022
NameSharesValueWeighting ↓
Parian Global Management LP 183,828$930,0004.26%
Velan Capital Investment Management LP 600,000$3,036,0003.08%
Triatomic Management LP 365,679$1,850,0001.70%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,383,099$17,118,0000.35%
Redmile Group, LLC 1,736,116$8,785,0000.34%
Saba Capital Management, L.P. 367,292$1,858,0000.02%
FMR LLC 12,000,078$60,720,0000.01%
BANK OF AMERICA CORP /DE/ 6,251$31,0000.00%
WELLS FARGO & COMPANY/MN 470$2,0000.00%
NORTHERN TRUST CORP 143,921$729,0000.00%
View complete list of THE ONCOLOGY INSTITUTE INC shareholders